MedPath

Effect of ageing on interpretation of disease activity measures and on cognition, physical activity and performance in patients with rheumatic disorders.

Recruiting
Conditions
musculoskeletal disorders
Rheumatic diseases
10003816
10013361
Registration Number
NL-OMON52497
Lead Sponsor
Medisch Universitair Ziekenhuis Maastricht
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
840
Inclusion Criteria

Inclusion criteria, RA population
- Age between 55 - 85 years at baseline.
- Diagnosis of RA by treating rheumatologist.
- Patients > 80 years who are physically unable to complete the whole study
procedure (i.e. geriatric patients who are considered frail by the
rheumatologist and/or patient itself), are allowed to undergo only part of the
study measurements. The rheumatologist who invites a patient > 80 years
explains this option to the patient; the patient is then allowed to choose
which measurement protocol suits him/her best.

Inclusion criteria, control population
- Age between 55 - 85 years at baseline.
- No diagnosis of RA, or other inflammatory RMD (osteoarthritis allowed).
- Controls > 80 years who are physically unable to complete the whole study
procedure (i.e. geriatric controls who are considered frail), are allowed to
undergo only part of the study measurements. The research assistant who
contacts the control after a control indicated his/her interest in the study,
explains this option to the control; the control is then allowed to choose
which measurement protocol suits him/her best.

Exclusion Criteria

Exclusiecriteria:
- Have severe comorbidity and the treating rheumatologist or research team
decides they should not be included in the study because of health reasons.
- Do not understand the Dutch language and/or are not able to understand the
study information.

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Primary objective: to investigate how measures of disease activity and measures<br /><br>for cognition, physical activity and performance behave in ageing population<br /><br>controls and RA patients. If an differential effect of age on outcome over time<br /><br>is apparent, the presence of an inclination point will be assessed. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Secondary objective: in case of differences between ageing RA patients and<br /><br>population controls, we will also investigate what additional factors might<br /><br>explain these differences.</p><br>
© Copyright 2025. All Rights Reserved by MedPath